The Tobacco Endgame Timeline: When Will the Last Cigarette Be Sold?

The cigarette will die. This is not in serious dispute—the combination of declining prevalence in high-income countries, increasing regulation globally, and the development of reduced-risk alternatives makes the long-term trajectory clear. What is in dispute is when. The most optimistic projections—New Zealand's original Smokefree 2025 goal, the 'tobacco-free generation' targets being discussed in multiple countries—envision a world in which commercial cigarette sales effectively end within the next two to three decades. The most pessimistic projections—which account for population growth in LMICs, the industry's aggressive marketing in developing markets, and the political obstacles to effective tobacco control—envision continued cigarette consumption at significant levels through the end of the century. **The gap between the optimistic and pessimistic timelines is measured in decades and millions of lives—and the variable that determines which timeline we follow is not scientific. It's political.**

**The high-income-country timeline is relatively clear.** In the US, UK, Australia, and Western Europe, smoking prevalence is declining at 3-5% annually, and the decline is accelerating in countries that have embraced harm reduction. If current trends continue, smoking prevalence in high-income countries will fall below 5% by approximately 2040-2050—the threshold at which the WHO considers a country 'smoke-free.' The cigarette market in these countries will not disappear—a residual population of older, heavily addicted, and marginalized smokers will persist—but it will become a niche product, like pipe tobacco or cigars. **The end of the cigarette in high-income countries is a matter of when, not if—and the 'when' is within the lifetimes of most people reading this article.**

**The LMIC timeline is fundamentally different.** In many low- and middle-income countries, smoking prevalence is stable or rising—driven by population growth, economic development (which makes cigarettes more affordable), and the industry's strategic focus on emerging markets. The WHO projects that tobacco-attributable mortality in LMICs will rise through at least 2050, driven by the latency period between smoking uptake and disease manifestation. The cigarette endgame in LMICs is not a near-term prospect. It is a multi-generational challenge that will require sustained investment in tobacco control infrastructure, cessation support, and economic alternatives to tobacco farming—investments that the global community has not yet shown any willingness to make at the necessary scale. **The cigarette will die first in the countries where it was born—and last in the countries that can least afford its continued presence.**

**The regulatory wildcard is the tobacco-free generation model.** New Zealand's generational ban (repealed by a change of government), the UK's consideration of similar measures, and the growing interest in 'sunset' provisions that phase out cigarette sales over time represent a regulatory approach that could accelerate the endgame dramatically. The model—prohibit the sale of cigarettes to anyone born after a certain date—would, if implemented and sustained, effectively end commercial cigarette sales within the lifespan of the affected generation. The political obstacles are formidable—the New Zealand experience demonstrated that even ambitious legislation can be reversed—but the model represents the most aggressive endgame strategy available. **A generational ban sustained for two decades would end the cigarette market in the implementing country. The question is whether any country can sustain the political will for two decades.**

**The industry variable is the most uncertain.** The major cigarette companies are simultaneously the primary obstacle to the endgame (they profit from continued cigarette sales) and the primary agents of the transition (they are investing in reduced-risk alternatives). The pace of the endgame depends on whether the industry's transition accelerates or stalls—and that depends on regulatory incentives, competitive dynamics, and the profitability of reduced-risk products relative to cigarettes. **A regulatory framework that makes reduced-risk products more profitable than cigarettes would accelerate the endgame by aligning the industry's financial interests with the public health goal. The current framework—which makes cigarettes profitable and reduced-risk products uncertain—does the opposite. The endgame timeline is, at its core, a function of the incentives the regulatory system creates for the industry—and those incentives can be changed.**

**💬 When do you think the last cigarette will be sold—in your country, and globally?** Will you see the end of the cigarette in your lifetime? And what would it take to accelerate the timeline?